|Document ID (ISN)||108325|
|Convention or series no.
||IARC Monographs Volume 90
World Health Organization (WHO)
||IARC monographs on the evaluation of carcinogenic risks to humans - Human papillomaviruses
||World Health Organization, Distribution and Sales Service, 1211 Genève 27, Switzerland, International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69372 Lyon Cedex 08, France 2007. viii, 670p. Illus. Bibl.ref. Index. Price: CHF 55.00 (CHF 38.50 in developing countries). Downloadable version free of charge.
||http://monographs.iarc.fr/ENG/Monographs/vol90/mono90.pdf [in English]
||Human papillomaviruses (HPVs) are common sexually-transmitted infectious agents. Although most infections are asymptomatic and are cleared within a period of two years, genital HPV infection can lead to clinical disease, including anogenital warts, cervical neoplasia, cervical cancer and other anogenital cancers. Of the many types of HPVs, some are classified as carcinogenic to humans (Group 1), others as probably carcinogenic to humans (Group 2A) and yet other as possibly carcinogenic to humans (Group 2B). Recent data includes strong evidence of carcinogenicity at sites other than the cervix. Vaccination can reduce the incidence of HPV-related genital diseases. However, such prophylactic treatments require that such vaccines be provided women for whom access to cervical cancer screening services is problematic. Therefore, the development of vaccines that are cheaper and easier to deliver remains highly desirable. Update of the IARC Monograph No.64 on the same subject (see CIS 96-1096).
||WHO; IARC; viruses; carcinogenic effects; warts; hazard evaluation; women; papillary tumours
||literature survey; rectal cancer; uterine cancer; criteria document; vaccination; glossary; epidemiologic study
||E - Books, reports, proceedings
|Country / State or Province||WHO|
||Toxic and dangerous substances
|Broad subject area(s)
Occupational medicine, epidemiology
Viral diseases (other than aids)
Bacterial and parasitic diseases